|
Parameter
|
Baseline
|
|---|
|
Age (years)
|
64 ± 11
|
|
Male:female (n)
|
44:6
|
|
Diabetes mellitus
|
30 (60%)
|
|
Arterial hypertension
|
38 (76%)
|
|
Hyperlipidemia
|
27 (54%)
|
|
BMI (kg/m2)
|
28 ± 4
|
|
LVEF (%)
|
55 ± 7
|
|
Smoking
|
21 (42%)
|
|
Rutherford category
|
5.1 ± 0.3
|
|
Creatinine (μmol/L)
|
95 ± 51
|
|
CRP (mg/L)
|
22 ± 37
|
|
Leukocytes (109/L)
|
9.1 ± 4.9
|
|
BM-MNCs in BMC (109 cells)
|
4.2 ± 1.5
|
|
CD34+ in BMC (106 cells)
|
28.1 ± 14.7
|
|
VEGF (pg/mL)
|
173 ± 191
|
|
Cholesterol (mmol/L)
|
4.3 ± 1.1
|
|
TAG (mmol/L)
|
1.4 ± 1.1
|
|
LDL (mmol/L)
|
2.8 ± 1.4
|
|
oxLDL (U/L)
|
24.3 ± 7.7
|
|
HDL (mmol/L)
|
1.2 ± 0.4
|
|
Atorvastatin (mg/day)
|
16 ± 11
|
-
BMC bone marrow concentrate, BMI body mass index, BM-MNC bone marrow-derived mononuclear cell, CRP C-reactive protein, HDL high-density lipoprotein, LDL low-density lipoprotein, LVEF left ventricle ejection fraction, oxLDL oxidized low-density lipoprotein, TAG triglycerides, VEGF vascular endothelial growth factor
